GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TTY Biopharm Co Ltd (ROCO:4105) » Definitions » E10

TTY Biopharm Co (ROCO:4105) E10 : NT$5.62 (As of Sep. 2024)


View and export this data going back to 2001. Start your Free Trial

What is TTY Biopharm Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

TTY Biopharm Co's adjusted earnings per share data for the three months ended in Sep. 2024 was NT$1.500. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$5.62 for the trailing ten years ended in Sep. 2024.

During the past 12 months, TTY Biopharm Co's average E10 Growth Rate was 9.10% per year. During the past 3 years, the average E10 Growth Rate was 7.60% per year. During the past 5 years, the average E10 Growth Rate was 5.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of TTY Biopharm Co was 7.60% per year. The lowest was 1.80% per year. And the median was 7.50% per year.

As of today (2024-12-11), TTY Biopharm Co's current stock price is NT$74.90. TTY Biopharm Co's E10 for the quarter that ended in Sep. 2024 was NT$5.62. TTY Biopharm Co's Shiller PE Ratio of today is 13.33.

During the past 13 years, the highest Shiller PE Ratio of TTY Biopharm Co was 21.08. The lowest was 12.95. And the median was 16.03.


TTY Biopharm Co E10 Historical Data

The historical data trend for TTY Biopharm Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TTY Biopharm Co E10 Chart

TTY Biopharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.96 4.17 4.49 4.92 5.20

TTY Biopharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.15 5.20 5.38 5.50 5.62

Competitive Comparison of TTY Biopharm Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, TTY Biopharm Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TTY Biopharm Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TTY Biopharm Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where TTY Biopharm Co's Shiller PE Ratio falls into.



TTY Biopharm Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, TTY Biopharm Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=1.5/133.0289*133.0289
=1.500

Current CPI (Sep. 2024) = 133.0289.

TTY Biopharm Co Quarterly Data

per share eps CPI Adj_EPS
201412 2.440 99.070 3.276
201503 0.400 99.621 0.534
201506 0.730 100.684 0.965
201509 0.970 100.392 1.285
201512 2.760 99.792 3.679
201603 1.130 100.470 1.496
201606 1.430 101.688 1.871
201609 0.850 101.861 1.110
201612 1.380 101.863 1.802
201703 0.890 102.862 1.151
201706 0.980 103.349 1.261
201709 1.120 104.136 1.431
201712 2.420 104.011 3.095
201803 1.030 105.290 1.301
201806 1.990 106.317 2.490
201809 1.380 106.507 1.724
201812 1.470 105.998 1.845
201903 1.180 107.251 1.464
201906 1.040 108.070 1.280
201909 1.270 108.329 1.560
201912 0.120 108.420 0.147
202003 1.020 108.902 1.246
202006 0.750 108.767 0.917
202009 0.890 109.815 1.078
202012 1.050 109.897 1.271
202103 0.820 111.754 0.976
202106 0.130 114.631 0.151
202109 1.020 115.734 1.172
202112 1.380 117.630 1.561
202203 0.910 121.301 0.998
202206 1.140 125.017 1.213
202209 1.360 125.227 1.445
202212 0.980 125.222 1.041
202303 0.960 127.348 1.003
202306 1.240 128.729 1.281
202309 1.510 129.860 1.547
202312 0.820 129.419 0.843
202403 1.130 131.776 1.141
202406 1.050 132.554 1.054
202409 1.500 133.029 1.500

Add all the adjusted EPS together and divide 10 will get our e10.


TTY Biopharm Co  (ROCO:4105) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

TTY Biopharm Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=74.90/5.62
=13.33

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of TTY Biopharm Co was 21.08. The lowest was 12.95. And the median was 16.03.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


TTY Biopharm Co E10 Related Terms

Thank you for viewing the detailed overview of TTY Biopharm Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


TTY Biopharm Co Business Description

Traded in Other Exchanges
N/A
Address
No. 3-1, Park Street, 3rd Floor, Nangang District, Taipei, TWN, 11503
TTY Biopharm Co Ltd is engaged in the manufacturing and marketing of pharmaceuticals and chemical drugs. The company's operating segments includes Oncology Business unit, Health Care Business unit, Intensive Care Business Unit, Healthcare Business Unit, Export and CDMO Business unit segment. It generates maximum revenue from the Oncology segment. Geographically, it derives a majority of revenue from Taiwan and also has a presence in European and Other Countries. Some of its products include Algitab, Alginos, Sulfin, Metacin, Cepiro, Brosym, Colimycin, Cubicin, and others.

TTY Biopharm Co Headlines

No Headlines